Astrana Health, Inc. (NASDAQ:ASTH) Given Average Rating of "Moderate Buy" by Brokerages

Key Points

• Analyst sentiment is positive: Astrana Health has a consensus “Moderate Buy” rating, with seven buy recommendations and two holds. The average 1-year price target is $49.43, above the recent $37.98 share price.
• Quarterly earnings exceeded expectations: The company reported $0.80 in EPS versus the $0.34 consensus estimate, while revenue rose 48.5% year over year to $972.5 million, slightly below forecasts.
• Institutional ownership remains substantial: Institutional investors own 52.77% of Astrana Health, with several firms recently increasing their positions. The stock has a market capitalization of approximately $2.12 billion.

Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the nine brokerages that are presently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $49.4286.

A number of research firms have issued reports on ASTH. Weiss Ratings reissued a "hold (c)" rating on shares of Astrana Health in a report on Thursday, August 27th. Truist Financial boosted their price target on Astrana Health from $47.00 to $55.00 and gave the company a "buy" rating in a research note on Monday, August 10th. BTIG Research increased their price target on Astrana Health from $50.00 to $65.00 and gave the stock a "buy" rating in a research report on Tuesday, July 14th. Barclays lifted their price objective on Astrana Health from $50.00 to $53.00 and gave the company an "overweight" rating in a report on Friday, August 7th. Finally, TD Cowen upped their target price on Astrana Health from $45.00 to $50.00 and gave the company a "buy" rating in a research report on Tuesday, July 14th.

Astrana Health Stock Down 0.1%

ASTH opened at $37.98 on Friday. The stock has a fifty day moving average of $39.97 and a 200-day moving average of $35.30. The company has a market capitalization of $2.12 billion, a P/E ratio of 46.32 and a beta of 0.90. Astrana Health has a fifty-two week low of $18.08 and a fifty-two week high of $51.60. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.23 and a current ratio of 1.23.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.34 by $0.46. Astrana Health had a net margin of 1.05% and a return on equity of 10.30%. The business had revenue of $972.52 million for the quarter, compared to the consensus estimate of $985.62 million. During the same period in the prior year, the company posted $0.19 earnings per share. Astrana Health's revenue was up 48.5% compared to the same quarter last year. On average, equities analysts expect that Astrana Health will post 1.32 EPS for the current year.

Institutional Investors Weigh In On Astrana Health

Several institutional investors and hedge funds have recently bought and sold shares of the company. Corient Private Wealth LP boosted its position in shares of Astrana Health by 1.6% during the 2nd quarter. Corient Private Wealth LP now owns 24,905 shares of the company's stock worth $1,156,000 after acquiring an additional 399 shares in the last quarter. Swiss National Bank raised its position in Astrana Health by 1.2% during the third quarter. Swiss National Bank now owns 86,944 shares of the company's stock valued at $2,465,000 after purchasing an additional 1,000 shares in the last quarter. Public Employees Retirement System of Ohio acquired a new position in Astrana Health during the second quarter valued at approximately $51,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Astrana Health by 5.2% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,768 shares of the company's stock worth $799,000 after purchasing an additional 1,263 shares during the last quarter. Finally, Deutsche Bank AG lifted its stake in Astrana Health by 3.9% during the fourth quarter. Deutsche Bank AG now owns 41,265 shares of the company's stock worth $1,024,000 after purchasing an additional 1,550 shares during the last quarter. Institutional investors own 52.77% of the company's stock.

About Astrana Health

Astrana Health, Inc is a healthcare management and technology company that helps physicians and healthcare organizations deliver value-based care. The company supports provider groups, independent physicians and health systems with clinical, operational and administrative services designed to coordinate care, improve outcomes and manage healthcare costs.

Astrana Health's platform includes care-management programs, analytics and population-health tools, technology solutions, physician practice support, and services for risk-bearing provider organizations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.